159 related articles for article (PubMed ID: 17906204)
21. Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancer.
Thor AD; Liu S; Edgerton S; Moore D; Kasowitz KM; Benz CC; Stern DF; DiGiovanna MP
J Clin Oncol; 2000 Sep; 18(18):3230-9. PubMed ID: 10986055
[TBL] [Abstract][Full Text] [Related]
22. Pathological significance of epidermal growth factor receptor expression and amplification in human gliomas.
Zhao LL; Xu KL; Wang SW; Hu BL; Chen LR
Histopathology; 2012 Oct; 61(4):726-36. PubMed ID: 22978472
[TBL] [Abstract][Full Text] [Related]
23. Role of epidermal growth factor receptor expression in primary breast cancer: results of a biochemical study and an immunocytochemical study.
Toi M; Tominaga T; Osaki A; Toge T
Breast Cancer Res Treat; 1994 Jan; 29(1):51-8. PubMed ID: 7912567
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor receptor in human breast cancer comparison with steroid receptors and other prognostic factors.
Cerra M; Cecco L; Montella M; Tuccillo F; Bonelli P; Botti G
Int J Biol Markers; 1995; 10(3):136-42. PubMed ID: 8551055
[TBL] [Abstract][Full Text] [Related]
25. Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors.
Frogne T; Laenkholm AV; Lyng MB; Henriksen KL; Lykkesfeldt AE
Breast Cancer Res; 2009; 11(1):R11. PubMed ID: 19239686
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapy.
Buchholz TA; Tu X; Ang KK; Esteva FJ; Kuerer HM; Pusztai L; Cristofanilli M; Singletary SE; Hortobagyi GN; Sahin AA
Cancer; 2005 Aug; 104(4):676-81. PubMed ID: 15981280
[TBL] [Abstract][Full Text] [Related]
27. Clinical effect of E-series of prostaglandin receptor 2 and epidermal growth factor receptor signal pathways in the development of esophageal squamous cell carcinoma.
Xu KK; Tian F; Chang D; Gong M; Fan JQ; Wang TY
Dis Esophagus; 2014; 27(4):388-95. PubMed ID: 24883443
[TBL] [Abstract][Full Text] [Related]
28. The prognostic value of epidermal growth factor receptor (EGFR) in breast cancer patients. Results of a follow-up study on 149 patients.
Railo MJ; Smitten KV; Pekonen F
Acta Oncol; 1994; 33(1):13-7. PubMed ID: 8142117
[TBL] [Abstract][Full Text] [Related]
29. Co-expression of EGFRvIII with ErbB-2 enhances tumorigenesis: EGFRvIII mediated constitutively activated and sustained signaling pathways, whereas EGF-induced a transient effect on EGFR-mediated signaling pathways.
Yu H; Gong X; Luo X; Han W; Hong G; Singh B; Tang CK
Cancer Biol Ther; 2008 Nov; 7(11):1818-28. PubMed ID: 18787418
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib.
Prat A; Cheang MC; Galván P; Nuciforo P; Paré L; Adamo B; Muñoz M; Viladot M; Press MF; Gagnon R; Ellis C; Johnston S
JAMA Oncol; 2016 Oct; 2(10):1287-1294. PubMed ID: 27281556
[TBL] [Abstract][Full Text] [Related]
31. GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer.
Arias-Pulido H; Royce M; Gong Y; Joste N; Lomo L; Lee SJ; Chaher N; Verschraegen C; Lara J; Prossnitz ER; Cristofanilli M
Breast Cancer Res Treat; 2010 Aug; 123(1):51-8. PubMed ID: 19902352
[TBL] [Abstract][Full Text] [Related]
32. Prognostic and predictive value of epidermal growth factor receptor in recurrent breast cancer.
Tsutsui S; Kataoka A; Ohno S; Murakami S; Kinoshita J; Hachitanda Y
Clin Cancer Res; 2002 Nov; 8(11):3454-60. PubMed ID: 12429634
[TBL] [Abstract][Full Text] [Related]
33. Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer.
Lee HJ; Seo AN; Kim EJ; Jang MH; Kim YJ; Kim JH; Kim SW; Ryu HS; Park IA; Im SA; Gong G; Jung KH; Kim HJ; Park SY
Br J Cancer; 2015 Jan; 112(1):103-11. PubMed ID: 25349977
[TBL] [Abstract][Full Text] [Related]
34. The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer.
de Graeff P; Crijns AP; Ten Hoor KA; Klip HG; Hollema H; Oien K; Bartlett JM; Wisman GB; de Bock GH; de Vries EG; de Jong S; van der Zee AG
Br J Cancer; 2008 Jul; 99(2):341-9. PubMed ID: 18628764
[TBL] [Abstract][Full Text] [Related]
35. Expression and prognostic value of EGFR in invasive breast cancer.
Quintela I; Corte MD; Allende MT; Vazquez J; Rodríguez JC; Bongera M; Lamelas M; Gonzalez LO; Vega A; García-Muñiz JL; Astudillo A; Vizoso F
Oncol Rep; 2005 Dec; 14(6):1655-63. PubMed ID: 16273272
[TBL] [Abstract][Full Text] [Related]
36. Expression of amphiregulin and epidermal growth factor receptor in human breast cancer: analysis of autocriny and stromal-epithelial interactions.
Ma L; de Roquancourt A; Bertheau P; Chevret S; Millot G; Sastre-Garau X; Espié M; Marty M; Janin A; Calvo F
J Pathol; 2001 Aug; 194(4):413-9. PubMed ID: 11523048
[TBL] [Abstract][Full Text] [Related]
37. Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status.
Rego RL; Foster NR; Smyrk TC; Le M; O'Connell MJ; Sargent DJ; Windschitl H; Sinicrope FA
Br J Cancer; 2010 Jan; 102(1):165-72. PubMed ID: 19997103
[TBL] [Abstract][Full Text] [Related]
38. Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.
Tolgay Ocal I; Dolled-Filhart M; D'Aquila TG; Camp RL; Rimm DL
Cancer; 2003 Apr; 97(8):1841-8. PubMed ID: 12673709
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
[TBL] [Abstract][Full Text] [Related]
40. Hormone receptor, HER2/NEU and EGFR expression in ovarian carcinoma--is here a prognostic phenotype?
Demir L; Yigit S; Sadullahoglu C; Akyol M; Cokmert S; Kucukzeybek Y; Alacacioglu A; Cakalagaoglu F; Tarhan MO
Asian Pac J Cancer Prev; 2014; 15(22):9739-45. PubMed ID: 25520097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
